Roche warns Trump's drug price order puts US investment at risk
Swiss pharma company Roche (ROG.SW, RHHBY) is warning that its investment into the US could be at risk due to President Trump's executive order calling for reductions in drug prices. Yahoo Finance senior health reporter Anjalee Khemlani shares more of the details. Catch Bernstein senior analyst Courtney Breen explain to Yahoo Finance why Trump's order is part request and part threat to drugmakers. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.
